Current disease status-First occurrence of the cancer - Page 17 of 59 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

What are the cardiovascular risks of surgical castration compared to hormone therapy?

What are the cardiovascular risks of surgical castration compared to hormone therapy?

Posted by on Oct 30, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to compare the risk of cardiovascular incidents (CIs, side-effects) of surgical castration versus castration achieved by hormone therapy. The study concluded that CIs were higher for surgical treatment at 1.5 years after treatment, but similar thereafter.  Some background For locally advanced or metastatic...

Read More

Is accelerated partial breast irradiation as good as whole breast irradiation?

Is accelerated partial breast irradiation as good as whole breast irradiation?

Posted by on Oct 23, 2017 in Breast cancer | 0 comments

In a nutshell This study examined accelerated partial breast irradiation (APBI) in comparison to whole breast irradiation (WBI) after surgery. They concluded that survival and long-term side-effects are the same for both treatments. However, ABPI had a higher rate of local recurrence as compared to WBI. Some background For early stage breast...

Read More

A treatment for fatigue in breast cancer patients who are undergoing chemotherapy

A treatment for fatigue in breast cancer patients who are undergoing chemotherapy

Posted by on Sep 30, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the effect of therapeutic care for fatigue in breast cancer patients who are undergoing chemotherapy. This study concluded that therapeutic care may decrease fatigue in breast cancer patients undergoing chemotherapy.  Some background The standard of care treatment option for breast cancer and...

Read More

Looking for patients with MET-mutated non-small cell lung cancer to test merestinib

Looking for patients with MET-mutated non-small cell lung cancer to test merestinib

Posted by on Sep 26, 2017 in Lung cancer | 0 comments

In a nutshell This phase 2 clinical trial will test the effectiveness of merestinib in non-small cell lung cancer patients with a mutation in the MET protein. The primary outcome will be measured by the overall response to the treatment. This study is being conducted in Boston, Massachusetts. The details Merestinib is an inhibitor of the C-Met...

Read More

Looking for patients with stage 4 or recurrent non-small cell lung cancer to test the effectiveness of a combined immunotherapy with chemotherapy

Looking for patients with stage 4 or recurrent non-small cell lung cancer to test the effectiveness of a combined immunotherapy with chemotherapy

Posted by on Sep 26, 2017 in Lung cancer | 0 comments

In a nutshell This phase 3 clinical trial will test the effectiveness of nivolumab (Opdivo), nivolumab with ipilimumab (Yervoy), or nivolumab with platinum-based chemotherapy compared with chemotherapy in treating patients with advanced non-small cell lung cancer (NSCLC). The primary outcome will be measured by the overall survival rate and time...

Read More

Identifying factors to predict treatment prognosis in EGFR positive non-small-cell lung cancer

Posted by on Sep 10, 2017 in Lung cancer | 0 comments

In a nutshell The authors examined whether the lymphocyte to monocyte ratio (LMR) could predict outcome in patients with late stage EGFR positive non-small-cell lung cancer (NSCLC). They concluded LMR could be beneficial in predicting outcome for patients with EGFR positive NSCLC patients receiving first-line EGFR-TKIs.   Some background Some...

Read More

Long-term quality of life in men who receive brachytherapy for prostate cancer

Posted by on Sep 10, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine long-term quality of life (QoL) in men with prostate cancer who received cesium-131 brachytherapy. The authors concluded that there are minimal long-term changes in urinary or bowel patient-reported QoL following Cs brachytherapy. Some background Radiation therapy is a form of treatment used in...

Read More

The effect of yoga in men with prostate cancer receiving radiation therapy

Posted by on Sep 10, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effects of yoga on fatigue, erectile dysfunction, urinary problems and quality of life (QoL) in men undergoing radiation therapy for prostate cancer. The authors concluded that yoga twice-weekly during external beam radiation therapy (EBRT) significantly reduced pre-existing and radiation-related...

Read More